Phase 2 Dose-finding, Double-blind Controlled Study of SFPP in Knee Osteoarthritis 2nd

Status

Unknown

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080220876

Enrollment

500

Registered

2009-09-26

Start date

2009-09-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis of the knee

Interventions

investigational material(s) Generic name etc : SFPP INN of investigational material : Therapeutic category code : 264 Analgesics, anti-itchings, astrigents and anti-inflammatory agents Dosage and Adm

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - Outpatient able to walk - Patients who agreed to X-ray diagnosis criteria: Kellegren-Lawrence grade 2-3. etc.

Exclusion criteria

Exclusion criteria: - Patients who underwent surgery (including arthroscopy) in their knees. - Patients with comorbid serious hepatic, renal, cardiac, or hematologic disease or malignancy etc.

Design outcomes

Primary

Measure	Time frame
Assessment of pain on a Visual Analogue Scale (VAS)	—

Secondary

Measure	Time frame
Changes in clinical symptoms (4 pain symptoms, 2 inflammatory symptoms, 3 impairments of activities of daily living)	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026